When hiring job candidates to work on cell and gene therapies, companies look for more than just technical skills. Talent ...

Scientists in Asia and Africa are racing to discover hardier crop varieties using gene editing tools. But patent restrictions ...

The biotech will cut 180 positions, or about two-thirds of its workforce, and discontinue development of its lead drug ...

A new kind of cancer gene therapy can be remotely activated at a specific part of the body. The team developed a version of ...

CRISPR-Cas tools allow researchers to modify individual building blocks of genetic material in a precise and targeted manner.

自CRISPR技术首次问世以来，已逾十年，其对生命科学与生物医学研究领域的变革性影响不容小觑。该技术显著缩短了动物模型的构建周期，为多物种新模型的开发提供了前所未有的机遇，加速并拓宽了筛选策略的应用范围，尤为重要的是，促进了针对先前难以治愈的遗传性疾 ...

CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...

Editas Medicine said on Thursday it would cut around 180 jobs, representing 65% of its workforce, over the next six months as part of the company's transition towards becoming a developer of therapies ...

Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the countr | The Vertex agreement is part of ...

An innovative CRISPR-Cas12f-based activator system may hold significant potential in the future of gene therapy and biological research, suggest researchers of a new study. Beremagene geperpavec ...

The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...